ULTRALIFE CORP (ULBI) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K, dated July 16, 2025, details the results of Ultralife Corporation's 2025 Annual Meeting of Stockholders. The meeting was held on July 16, 2025, with a record date of May 22, 2025.
Key Financial Metrics
This filing is a corporate governance report and does not contain financial performance data. The filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes and Voting Results
As of the record date, 16,632,965 shares of common stock were outstanding. A quorum was established with 14,196,720 shares (85.35%) present in person or by proxy. The following proposals were approved:
- Election of Directors: Stockholders elected five directors to serve one-year terms. All nominees received majority support, though significant broker non-votes were recorded for each candidate.
- Ratification of Auditors: Stockholders ratified the selection of Freed Maxick P.C. as the independent registered public accounting firm for 2025.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. It is limited strictly to the reporting of stockholder voting outcomes.
Key Facts for Investor Verification
- Verify the composition of the newly elected Board of Directors: Michael E. Manna, Janie Goddard, Thomas L. Saeli, Robert W. Shaw II, and Bradford T. Whitmore.
- Note the high volume of broker non-votes (2,940,419 shares) in the director elections, indicating shares held by brokers that could not be voted without specific instructions.
- Confirm the ratification of Freed Maxick P.C. as the independent auditor for the 2025 fiscal year.
- Review the company's most recent 10-K or 10-Q for actual financial performance metrics, as this 8-K does not include them.